Tag: Andrew Grieve
August 14, 2019
Zenabis Global Announces Q2 2019 Results
Zenabis Global (TSX:ZENA) released its financial results for the second quarter that ended on June 30, 2019. As quoted in the press release:... July 29, 2019
Zenabis Increases Licensed Annual Cultivation Capacity
Zenabis Global (TSX:ZENA) announced Monday (July 29) the licensing of Phase 2C – Part 1 at their facility in Atholville, New... July 22, 2019
Zenabis Arranges C$10 Million Non-Dilutive Financing via Supply Agreement with Starseed
Zenabis Global (TSX:ZENA) announced today that it has entered into an agreement with Starseed Medicinal who will advance C$10 million to... July 11, 2019
Zenabis Closes $30 Million Non-Dilutive Financing via Agreement with Tilray
Zenabis Global’s (TSX:ZENA) subsidiary, Zenabis Ltd., has closed its non-dilutive financing via a pre-paid supply agreement with High Park Holdings, a wholly-owned... July 2, 2019
Zenabis Inks Supply Deal with Tilray
Zenabis Global announced an agreement with Tilray subsidiary High Park Holdings for a dried cannabis supply worth an advance of C$30 million. June 3, 2019
Zenabis Shares Production License Update
Zenabis Global announced it obtained an industrial hemp production license from Health Canada. May 13, 2019